Concepedia

Towards a comprehensive safety understanding of granulocyte-colony stimulating factor biosimilars in treating chemotherapy associated febrile neutropenia: Trends from decades of data

Shruti Rastogi, Shatrunajay Shukla, Arvind Kumar Sharma, Maryam Sarwat, Pranay Srivastava, Tridiv Katiyar, Vivekanandan Kalaiselvan, Gyanendra Nath Singh

Toxicology and Applied Pharmacology · 2020 · 11 citations · 30 references

DOI

Concepts

References

30

Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

Stephen Evans, Patrick Waller, Sarah Davis · Pharmacoepidemiology and Drug Safety · 2001 · 1.7K citations

, , +16

Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study

Joe‐Elie Salem, Ali Manouchehri, Melissa Moey et al. · The Lancet Oncology · 2018 · 1.2K citations

, , +16

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients

Nicole M. Kuderer, David C. Dale, Jeffrey Crawford et al. · Cancer · 2006 · 1.2K citations · Full text

, , +6

Filgrastim (r-metHuG-CSF): the first 10 years

Karl Welte, Janice Gabrilove, MH Bronchud et al. · Blood · 1996 · 610 citations · Full text

, , +2

Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications

Jeffrey Crawford, Claudia Caserta, F. Roila · Annals of Oncology · 2010 · 236 citations · Full text

, , +14